Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer.
Frances WillenbrockCatrin M CoxEileen E ParkesCharlotte S Wilhelm-BenartziAswin G AbrahamRobert OwensAhmad SabbaghChristopher M JonesDaniel L I HughesTim MaughanChristopher N HurtEric E O'NeillSomnath MukherjeePublished in: British journal of cancer (2020)
The SCALOP trial was registered with ISRCTN, number 96169987 (registered 29 May 2008).